The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Codeine Narcotic Market Research Report 2025
Synopsis
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Codeine Narcotic market was valued at US$ 681.5 million in 2023 and is anticipated to reach US$ 965 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
This report aims to provide a comprehensive presentation of the global market for Codeine Narcotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine Narcotic.
Report Scope
The Codeine Narcotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Codeine Narcotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine Narcotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Codeine Narcotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Codeine Narcotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Codeine Narcotic market was valued at US$ 681.5 million in 2023 and is anticipated to reach US$ 965 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
This report aims to provide a comprehensive presentation of the global market for Codeine Narcotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine Narcotic.
Report Scope
The Codeine Narcotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Codeine Narcotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine Narcotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Codeine Narcotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Codeine Narcotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Codeine Narcotic Market Overview
1.1 Product Overview and Scope of Codeine Narcotic
1.2 Codeine Narcotic Segment by Type
1.2.1 Global Codeine Narcotic Market Value Comparison by Type (2024-2030)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine Narcotic Segment by Application
1.3.1 Global Codeine Narcotic Market Value by Application: (2024-2030)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Narcotic Market Size Estimates and Forecasts
1.4.1 Global Codeine Narcotic Revenue 2019-2030
1.4.2 Global Codeine Narcotic Sales 2019-2030
1.4.3 Global Codeine Narcotic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Codeine Narcotic Market Competition by Manufacturers
2.1 Global Codeine Narcotic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Codeine Narcotic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Codeine Narcotic Average Price by Manufacturers (2019-2024)
2.4 Global Codeine Narcotic Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Codeine Narcotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Codeine Narcotic, Product Type & Application
2.7 Codeine Narcotic Market Competitive Situation and Trends
2.7.1 Codeine Narcotic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Codeine Narcotic Players Market Share by Revenue
2.7.3 Global Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Codeine Narcotic Retrospective Market Scenario by Region
3.1 Global Codeine Narcotic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Codeine Narcotic Global Codeine Narcotic Sales by Region: 2019-2030
3.2.1 Global Codeine Narcotic Sales by Region: 2019-2024
3.2.2 Global Codeine Narcotic Sales by Region: 2025-2030
3.3 Global Codeine Narcotic Global Codeine Narcotic Revenue by Region: 2019-2030
3.3.1 Global Codeine Narcotic Revenue by Region: 2019-2024
3.3.2 Global Codeine Narcotic Revenue by Region: 2025-2030
3.4 North America Codeine Narcotic Market Facts & Figures by Country
3.4.1 North America Codeine Narcotic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Codeine Narcotic Sales by Country (2019-2030)
3.4.3 North America Codeine Narcotic Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Codeine Narcotic Market Facts & Figures by Country
3.5.1 Europe Codeine Narcotic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Codeine Narcotic Sales by Country (2019-2030)
3.5.3 Europe Codeine Narcotic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Codeine Narcotic Market Facts & Figures by Country
3.6.1 Asia Pacific Codeine Narcotic Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Codeine Narcotic Sales by Country (2019-2030)
3.6.3 Asia Pacific Codeine Narcotic Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Codeine Narcotic Market Facts & Figures by Country
3.7.1 Latin America Codeine Narcotic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Codeine Narcotic Sales by Country (2019-2030)
3.7.3 Latin America Codeine Narcotic Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Codeine Narcotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Codeine Narcotic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Codeine Narcotic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Codeine Narcotic Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Codeine Narcotic Sales by Type (2019-2030)
4.1.1 Global Codeine Narcotic Sales by Type (2019-2024)
4.1.2 Global Codeine Narcotic Sales by Type (2025-2030)
4.1.3 Global Codeine Narcotic Sales Market Share by Type (2019-2030)
4.2 Global Codeine Narcotic Revenue by Type (2019-2030)
4.2.1 Global Codeine Narcotic Revenue by Type (2019-2024)
4.2.2 Global Codeine Narcotic Revenue by Type (2025-2030)
4.2.3 Global Codeine Narcotic Revenue Market Share by Type (2019-2030)
4.3 Global Codeine Narcotic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Codeine Narcotic Sales by Application (2019-2030)
5.1.1 Global Codeine Narcotic Sales by Application (2019-2024)
5.1.2 Global Codeine Narcotic Sales by Application (2025-2030)
5.1.3 Global Codeine Narcotic Sales Market Share by Application (2019-2030)
5.2 Global Codeine Narcotic Revenue by Application (2019-2030)
5.2.1 Global Codeine Narcotic Revenue by Application (2019-2024)
5.2.2 Global Codeine Narcotic Revenue by Application (2025-2030)
5.2.3 Global Codeine Narcotic Revenue Market Share by Application (2019-2030)
5.3 Global Codeine Narcotic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Corporation Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Taiji Codeine Narcotic Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Corporation Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mallinckrodt Codeine Narcotic Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TEVA Codeine Narcotic Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Codeine Narcotic Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Corporation Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medreich Codeine Narcotic Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Corporation Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Aventis Codeine Narcotic Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Codeine Narcotic Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Corporation Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hikma Codeine Narcotic Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Corporation Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pharmaceutical Associates Codeine Narcotic Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Codeine Narcotic Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Codeine Narcotic Description and Business Overview
6.11.3 Apotex Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Apotex Codeine Narcotic Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Corporation Information
6.12.2 Mylan Codeine Narcotic Description and Business Overview
6.12.3 Mylan Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Mylan Codeine Narcotic Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Corporation Information
6.13.2 Aristo Pharma GmbH Codeine Narcotic Description and Business Overview
6.13.3 Aristo Pharma GmbH Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Aristo Pharma GmbH Codeine Narcotic Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Corporation Information
6.14.2 Lannett Company Codeine Narcotic Description and Business Overview
6.14.3 Lannett Company Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lannett Company Codeine Narcotic Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Corporation Information
6.15.2 Laboratoire Riva Codeine Narcotic Description and Business Overview
6.15.3 Laboratoire Riva Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Laboratoire Riva Codeine Narcotic Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Codeine Narcotic Industry Chain Analysis
7.2 Codeine Narcotic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Codeine Narcotic Production Mode & Process
7.4 Codeine Narcotic Sales and Marketing
7.4.1 Codeine Narcotic Sales Channels
7.4.2 Codeine Narcotic Distributors
7.5 Codeine Narcotic Customers
8 Codeine Narcotic Market Dynamics
8.1 Codeine Narcotic Industry Trends
8.2 Codeine Narcotic Market Drivers
8.3 Codeine Narcotic Market Challenges
8.4 Codeine Narcotic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Codeine Narcotic Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Codeine Narcotic Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Codeine Narcotic Market Competitive Situation by Manufacturers in 2023
Table 4. Global Codeine Narcotic Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Codeine Narcotic Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Codeine Narcotic Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Codeine Narcotic Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Codeine Narcotic Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Codeine Narcotic, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Codeine Narcotic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Codeine Narcotic, Product Type & Application
Table 12. Global Key Manufacturers of Codeine Narcotic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Codeine Narcotic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine Narcotic as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Codeine Narcotic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Codeine Narcotic Sales by Region (2019-2024) & (K Units)
Table 18. Global Codeine Narcotic Sales Market Share by Region (2019-2024)
Table 19. Global Codeine Narcotic Sales by Region (2025-2030) & (K Units)
Table 20. Global Codeine Narcotic Sales Market Share by Region (2025-2030)
Table 21. Global Codeine Narcotic Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Codeine Narcotic Revenue Market Share by Region (2019-2024)
Table 23. Global Codeine Narcotic Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Codeine Narcotic Revenue Market Share by Region (2025-2030)
Table 25. North America Codeine Narcotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Codeine Narcotic Sales by Country (2019-2024) & (K Units)
Table 27. North America Codeine Narcotic Sales by Country (2025-2030) & (K Units)
Table 28. North America Codeine Narcotic Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Codeine Narcotic Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Codeine Narcotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Codeine Narcotic Sales by Country (2019-2024) & (K Units)
Table 32. Europe Codeine Narcotic Sales by Country (2025-2030) & (K Units)
Table 33. Europe Codeine Narcotic Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Codeine Narcotic Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Codeine Narcotic Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Codeine Narcotic Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Codeine Narcotic Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Codeine Narcotic Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Codeine Narcotic Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Codeine Narcotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Codeine Narcotic Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Codeine Narcotic Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Codeine Narcotic Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Codeine Narcotic Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Codeine Narcotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Codeine Narcotic Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Codeine Narcotic Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Codeine Narcotic Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Codeine Narcotic Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Codeine Narcotic Sales (K Units) by Type (2019-2024)
Table 51. Global Codeine Narcotic Sales (K Units) by Type (2025-2030)
Table 52. Global Codeine Narcotic Sales Market Share by Type (2019-2024)
Table 53. Global Codeine Narcotic Sales Market Share by Type (2025-2030)
Table 54. Global Codeine Narcotic Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Codeine Narcotic Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Codeine Narcotic Revenue Market Share by Type (2019-2024)
Table 57. Global Codeine Narcotic Revenue Market Share by Type (2025-2030)
Table 58. Global Codeine Narcotic Price (US$/Unit) by Type (2019-2024)
Table 59. Global Codeine Narcotic Price (US$/Unit) by Type (2025-2030)
Table 60. Global Codeine Narcotic Sales (K Units) by Application (2019-2024)
Table 61. Global Codeine Narcotic Sales (K Units) by Application (2025-2030)
Table 62. Global Codeine Narcotic Sales Market Share by Application (2019-2024)
Table 63. Global Codeine Narcotic Sales Market Share by Application (2025-2030)
Table 64. Global Codeine Narcotic Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Codeine Narcotic Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Codeine Narcotic Revenue Market Share by Application (2019-2024)
Table 67. Global Codeine Narcotic Revenue Market Share by Application (2025-2030)
Table 68. Global Codeine Narcotic Price (US$/Unit) by Application (2019-2024)
Table 69. Global Codeine Narcotic Price (US$/Unit) by Application (2025-2030)
Table 70. Taiji Corporation Information
Table 71. Taiji Description and Business Overview
Table 72. Taiji Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Taiji Codeine Narcotic Product
Table 74. Taiji Recent Developments/Updates
Table 75. Mallinckrodt Corporation Information
Table 76. Mallinckrodt Description and Business Overview
Table 77. Mallinckrodt Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Mallinckrodt Codeine Narcotic Product
Table 79. Mallinckrodt Recent Developments/Updates
Table 80. TEVA Corporation Information
Table 81. TEVA Description and Business Overview
Table 82. TEVA Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. TEVA Codeine Narcotic Product
Table 84. TEVA Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson Codeine Narcotic Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Medreich Corporation Information
Table 91. Medreich Description and Business Overview
Table 92. Medreich Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Medreich Codeine Narcotic Product
Table 94. Medreich Recent Developments/Updates
Table 95. Sanofi Aventis Corporation Information
Table 96. Sanofi Aventis Description and Business Overview
Table 97. Sanofi Aventis Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sanofi Aventis Codeine Narcotic Product
Table 99. Sanofi Aventis Recent Developments/Updates
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Cipla Codeine Narcotic Product
Table 104. Cipla Recent Developments/Updates
Table 105. Hikma Corporation Information
Table 106. Hikma Description and Business Overview
Table 107. Hikma Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hikma Codeine Narcotic Product
Table 109. Hikma Recent Developments/Updates
Table 110. Pharmaceutical Associates Corporation Information
Table 111. Pharmaceutical Associates Description and Business Overview
Table 112. Pharmaceutical Associates Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Pharmaceutical Associates Codeine Narcotic Product
Table 114. Pharmaceutical Associates Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novartis Codeine Narcotic Product
Table 119. Novartis Recent Developments/Updates
Table 120. Apotex Corporation Information
Table 121. Apotex Description and Business Overview
Table 122. Apotex Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Apotex Codeine Narcotic Product
Table 124. Apotex Recent Developments/Updates
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Mylan Codeine Narcotic Product
Table 129. Mylan Recent Developments/Updates
Table 130. Aristo Pharma GmbH Corporation Information
Table 131. Aristo Pharma GmbH Description and Business Overview
Table 132. Aristo Pharma GmbH Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Aristo Pharma GmbH Codeine Narcotic Product
Table 134. Aristo Pharma GmbH Recent Developments/Updates
Table 135. Lannett Company Corporation Information
Table 136. Lannett Company Description and Business Overview
Table 137. Lannett Company Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Lannett Company Codeine Narcotic Product
Table 139. Lannett Company Recent Developments/Updates
Table 140. Laboratoire Riva Corporation Information
Table 141. Laboratoire Riva Description and Business Overview
Table 142. Laboratoire Riva Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Laboratoire Riva Codeine Narcotic Product
Table 144. Laboratoire Riva Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Codeine Narcotic Distributors List
Table 148. Codeine Narcotic Customers List
Table 149. Codeine Narcotic Market Trends
Table 150. Codeine Narcotic Market Drivers
Table 151. Codeine Narcotic Market Challenges
Table 152. Codeine Narcotic Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Codeine Narcotic
Figure 2. Global Codeine Narcotic Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Codeine Narcotic Market Share by Type in 2023 & 2030
Figure 4. Single-ingredient Codeine Product Picture
Figure 5. Multi-ingredient Medications Product Picture
Figure 6. Global Codeine Narcotic Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Codeine Narcotic Market Share by Application in 2023 & 2030
Figure 8. Narcotic Analgesic
Figure 9. Antitussive
Figure 10. Others
Figure 11. Global Codeine Narcotic Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Codeine Narcotic Market Size (2019-2030) & (US$ Million)
Figure 13. Global Codeine Narcotic Sales (2019-2030) & (K Units)
Figure 14. Global Codeine Narcotic Average Price (US$/Unit) & (2019-2030)
Figure 15. Codeine Narcotic Report Years Considered
Figure 16. Codeine Narcotic Sales Share by Manufacturers in 2023
Figure 17. Global Codeine Narcotic Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Codeine Narcotic Players: Market Share by Revenue in 2023
Figure 19. Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Codeine Narcotic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Codeine Narcotic Sales Market Share by Country (2019-2030)
Figure 22. North America Codeine Narcotic Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Codeine Narcotic Sales Market Share by Country (2019-2030)
Figure 26. Europe Codeine Narcotic Revenue Market Share by Country (2019-2030)
Figure 27. Germany Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Codeine Narcotic Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Codeine Narcotic Revenue Market Share by Region (2019-2030)
Figure 34. China Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Codeine Narcotic Sales Market Share by Country (2019-2030)
Figure 45. Latin America Codeine Narcotic Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Codeine Narcotic Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Codeine Narcotic Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Codeine Narcotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Codeine Narcotic by Type (2019-2030)
Figure 55. Global Revenue Market Share of Codeine Narcotic by Type (2019-2030)
Figure 56. Global Codeine Narcotic Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Codeine Narcotic by Application (2019-2030)
Figure 58. Global Revenue Market Share of Codeine Narcotic by Application (2019-2030)
Figure 59. Global Codeine Narcotic Price (US$/Unit) by Application (2019-2030)
Figure 60. Codeine Narcotic Value Chain
Figure 61. Codeine Narcotic Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
